226 hedge funds and large institutions have $1.72B invested in Genmab in 2020 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 85 increasing their positions, 63 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

14% more funds holding

Funds holding: 198226 (+28)

1.83% more ownership

Funds ownership: 62.58%64.42% (+1.8%)

4% more call options, than puts

Call options by funds: $3.57M | Put options by funds: $3.44M

Holders
226
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.57M
Puts
$3.44M
Net Calls
Net Calls Change

Top Buyers

1 +$21.9M
2 +$14.9M
3 +$14.4M
4
Jennison Associates
Jennison Associates
New York
+$14.2M
5
1832 Asset Management
1832 Asset Management
Ontario, Canada
+$11.4M

Top Sellers

1 -$18.3M
2 -$14.3M
3 -$14.1M
4
Morgan Stanley
Morgan Stanley
New York
-$13.2M
5
Artisan Partners
Artisan Partners
Wisconsin
-$12.9M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$353K
127
$352K
128
$345K
129
$334K
130
$327K
131
$323K
132
$323K
133
$318K
134
$300K
135
$296K
136
$295K
137
$287K
138
$286K
139
$270K
140
$268K
141
$261K
142
$254K
143
$231K
144
$228K
145
$226K
146
$223K
147
$220K
148
$220K
149
$219K
150
$215K